Type V CRISPR-Cas systems and use thereof
US11639523B2 · kind B2 · utility
0Cited by
4References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 5, 2020 |
| Grant date | May 2, 2023 |
| Priority date | — |
| Expiry date | Jun 5, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/165
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Engineered or non-naturally occurring systems and compositions comprising a novel Cas12b and a guide molecule. Also provided include methods of use the systems and compositions, including in treating and diagnosing diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.